The role of system Xc− in methamphetamine‐induced dopaminergic neurotoxicity in mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurochemistry International

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuint.2017.04.013PMID 28457879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice

  2017cited by this paper
• Astroglial glutamate transporters coordinate excitatory signaling and brain energetics.

  2016cited by this paper
• Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK

  2016influential reference
• Main path and byways: non‐vesicular glutamate release by system xc− as an important modifier of glutamatergic neurotransmission

  2015cited by this paper
• Liposomal melatonin rescues methamphetamine‐elicited mitochondrial burdens, pro‐apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene

  2015influential reference
• Inhibition of System Xc− Transporter Attenuates Autoimmune Inflammatory Demyelination

  2015cited by this paper
• MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.

  2015cited by this paper
• The GLT‐1 (EAAT2; slc1a2) glutamate transporter is essential for glutamate homeostasis in the neocortex of the mouse

  2014cited by this paper
• Ginsenoside Re Rescues Methamphetamine-Induced Oxidative Damage, Mitochondrial Dysfunction, Microglial Activation, and Dopaminergic Degeneration by Inhibiting the Protein Kinase Cδ Gene

  2014cited by this paper
• Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining

  2014cited by this paper
• A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

  2013cited by this paper
• Presynaptic kainate receptor‐mediated facilitation of glutamate release involves Ca2+–calmodulin and PKA in cerebrocortical synaptosomes

  2013cited by this paper
• Mechanisms of glutamate transport.

  2013cited by this paper
• SLC1 glutamate transporters

  2013cited by this paper
• A Single Neurotoxic Dose of Methamphetamine Induces a Long-Lasting Depressive-Like Behaviour in Mice

  2013cited by this paper
• Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.

  2012influential reference
• Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates

  2012influential reference
• Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice

  2012influential reference
• The Density of EAAC1 (EAAT3) Glutamate Transporters Expressed by Neurons in the Mammalian CNS

  2012cited by this paper
• System xc‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS

  2012influential reference
• Protective potential of IL-6 against trimethyltin-induced neurotoxicity in vivo.

  2012cited by this paper
• Dopaminergic neurons of system xc–‐deficient mice are highly protected against 6‐hydroxydopamine‐induced toxicity

  2011cited by this paper
• The oxidative stress-inducible cystine/glutamate antiporter, system xc−: cystine supplier and beyond

  2011influential reference
• Loss of System xc− Does Not Induce Oxidative Stress But Decreases Extracellular Glutamate in Hippocampus and Influences Spatial Working Memory and Limbic Seizure Susceptibility

  2011cited by this paper
• Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration.

  2010cited by this paper
• Increased levels of glutamate in the central nervous system are associated with behavioral symptoms in experimental malaria.

  2010cited by this paper
• Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor‐κB

  2009cited by this paper
• Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro

  2009cited by this paper
• Molecular bases of methamphetamine-induced neurodegeneration.

  2009cited by this paper
• A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis

  2008cited by this paper
• Modulation of Dopaminergic and Glutamatergic Brain Function: PET Studies on Parkinsonian Rats

  2007influential reference
• System xc− and Glutamate Transporter Inhibition Mediates Microglial Toxicity to Oligodendrocytes1

  2007cited by this paper
• Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease

  2007cited by this paper
• Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement

  2007cited by this paper
• The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

  2007cited by this paper
• Ciliary Neurotrophic Factor Activates Astrocytes, Redistributes Their Glutamate Transporters GLAST and GLT-1 to Raft Microdomains, and Improves Glutamate Handling In Vivo

  2006cited by this paper
• Computerized Morphometric Analysis of Pathological Prion Protein Deposition in Scrapie-Infected Hamster Brain

  2006influential reference
• Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.

  2006cited by this paper
• Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration.

  2006cited by this paper
• Tumor Necrosis Factor-α Induces Neurotoxicity via Glutamate Release from Hemichannels of Activated Microglia in an Autocrine Manner*

  2006cited by this paper
• Decreased Expression of Glutamate Transporters in Astrocytes after Human Traumatic Brain Injury

  2006cited by this paper
• 3‐Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP‐elicited damage both in vivo and in vitro

  2006cited by this paper
• Glutamate‐mediated glial injury: Mechanisms and clinical importance

  2006cited by this paper
• Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc– protects from oxidative glutamate toxicity

  2006cited by this paper
• The glutamate‐glutamine cycle as an inducible, protective face of macrophage activation

  2006cited by this paper
• Circadian responses to endotoxin treatment in mice.

  2005cited by this paper
• Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors

  2005cited by this paper
• Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: prevention by guanosine.

  2005cited by this paper
• Protective autoimmunity: interferon‐γ enables microglia to remove glutamate without evoking inflammatory mediators

  2005cited by this paper
• Ascorbate attenuates trimethyltin-induced oxidative burden and neuronal degeneration in the rat hippocampus by maintaining glutathione homeostasis.

  2005cited by this paper
• Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man

  2005cited by this paper
• Acute up‐regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes

  2005cited by this paper
• Lipopolysaccharide increases microglial GLT‐1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF‐α

  2005cited by this paper
• Redox Imbalance in Cystine/Glutamate Transporter-deficient Mice*

  2005cited by this paper
• Glutamate transporters: animal models to neurologic disease.

  2004cited by this paper
• Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control

  2004influential reference
• Electrogenic Glutamate Transporters in the CNS: Molecular Mechanism, Pre-steady-state Kinetics, and their Impact on Synaptic Signaling

  2004cited by this paper
• Protective autoimmunity against the enemy within: fighting glutamate toxicity.

  2003cited by this paper
• The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate

  2002cited by this paper
• Glutamate uptake.

  2001cited by this paper
• The group I metabotropic glutamate receptor antagonist S‐4‐CPG modulates the locomotor response produced by the activation of D1‐like, but not D2‐like, dopamine receptors in the rat nucleus accumbens

  2001cited by this paper
• Ability of rat microglia to uptake extracellular glutamate.

  2001cited by this paper
• Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms.

  2000cited by this paper
• Glutamate excitotoxicity in a model of multiple sclerosis

  2000cited by this paper
• Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages*

  2000cited by this paper
• Na+-Dependent High-Affinity Glutamate Transport in Macrophages1

  2000cited by this paper
• Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model.

  2000cited by this paper
• Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins*

  1999cited by this paper
• Traumatic Brain Injury Down‐Regulates Glial Glutamate Transporter (GLT‐1 and GLAST) Proteins in Rat Brain

  1998cited by this paper
• Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

  1997influential reference
• Brain Glutamate Transporter Proteins Form Homomultimers*

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Peroxynitrite Inhibits Glutamate Transporter Subtypes (*)

  1996cited by this paper
• Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

  1996cited by this paper
• Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes

  1994cited by this paper
• Rat cortical synaptosomes have more than one mechanism for Ca2+ entry linked to rapid glutamate release: studies using the Phoneutria nigriventer toxin PhTX2 and potassium depolarization.

  1993cited by this paper
• The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.

  1990cited by this paper
• Calcium‐Dependent and‐Independent Release of Glutamate from Synaptosomes Monitored by Continuous Fluorometry

  1987influential reference
• Age-related changes in oxidized proteins.

  1987cited by this paper
• Synaptosomes possess an exocytotic pool of glutamate

  1986cited by this paper
• High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides.

  1980cited by this paper
• Distribution studies of salicylazosulfapyridine and its metabolites.

  1973cited by this paper
• Absorption, metabolism, and excretion of salicylazosulfapyridine in man

  1972cited by this paper

• Critical interplay between PAF receptor and PKCδ is involved in dopaminergic insult evoked by methamphetamine in mice.

  2025cites this paper
• Up-regulation of Oxidative Burden, NFκB, and D1 Receptor Is Involved in the Neuropsychotoxic Behaviors Induced by Camfetamine, a New Psychoactive Substance; Involvements of the Neuromodulation by GPx-1 Gene

  2025cites this paper
• Research trends and hotspots of ferroptosis in neurodegenerative diseases from 2013 to 2023: A bibliometrics study

  2024cites this paper
• The Common Denominators of Parkinson’s Disease Pathogenesis and Methamphetamine Abuse

  2023cites this paper
• The solute carrier family 7 member 11 (SLC7A11) is regulated by LH/androgen and required for cystine/glutathione homeostasis in mouse Sertoli cells.

  2022cites this paper
• Nanoparticle-induced Ferroptosis for Cancer Therapy

  2022cites this paper
• Ginsenoside Re attenuates 8-OH-DPAT-induced serotonergic behaviors in mice via interactive modulation between PKCδ gene and Nrf2

  2022cites this paper
• Retention of higher fertility depending on ovarian follicle reserve in cystine-glutamate transporter gene-deficient mice

  2022cites this paper
• Biological protein mediated ferroptotic tumor nanotherapeutics.

  2021cites this paper
• Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease

  2021cites this paper
• Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway

  2021cites this paper
• Protein kinase Cδ mediates methamphetamine-induced dopaminergic neurotoxicity in mice via activation of microsomal epoxide hydrolase.

  2019cites this paper
• Nanomaterial-induced ferroptosis for cancer specific therapy

  2019cites this paper
• Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors.

  2019cites this paper
• 5-HT1A receptor agonist 8-OH-DPAT induces serotonergic behaviors in mice via interaction between PKCδ and p47phox.

  2019cites this paper
• Role of dopamine D1 receptor in 3‐fluoromethamphetamine‐induced neurotoxicity in mice

  2018cites this paper
• Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor

  2018cites this paper
• Mn Inhibits GSH Synthesis via Downregulation of Neuronal EAAC1 and Astrocytic xCT to Cause Oxidative Damage in the Striatum of Mice

  2018cites this paper
• Nrf2-Mediated System xc− Activation in Astroglial Cells Is Involved in HIV-1 Tat-Induced Neurotoxicity

  2018cites this paper
• PKC&dgr;‐dependent p47phox activation mediates methamphetamine‐induced dopaminergic neurotoxicity

  2018cites this paper